Vision-language-action models (VLAs) trained on large-scale robotic datasets have demonstrated strong performance on manipulation tasks, including bimanual tasks. However, because most public datasets ...
Just after Christmas 2023, a chemist at the state public health laboratory admitted to her bosses that she had manipulated test results. In the coming weeks her supervisors at the Colorado Department ...
*A December 14 report from the House Committee on Oversight and Government Reform alleges that outgoing D.C. Police Chief Pamela A. Smith deliberately pressured her commanders to manipulate crime ...
WASHINGTON — The controversy surrounding the accuracy of Washington, D.C.'s crime statistics intensified tonight after the District’s top federal prosecutor publicly supported a Congressional ...
Ascletis Pharma Inc. shares surged Tuesday, posting their biggest rally since April, after mid-stage results for its oral weight-loss drug suggested a potential best-in-class profile. The highest dose ...
Te Whatu Ora Health New Zealand Digital Services has started a national project to standardise oral health data in the New Zealand public health system. This comes as it moves towards national ...
The new managed functions will let enterprises apply LLM reasoning to structured and unstructured data directly in SQL, eliminating prompt tuning and external tools. Google has boosted its BigQuery ...
Microsoft studied interactions between AI customers and vendors. Most agents failed to resist manipulation and make wise choices. The results underscore the dangers of an AI agent-run economy. As ...
Mortgage-pricing data has gone digital. But when does transparency turn into coordination? In early October 2025, mortgage-technology provider Optimal Blue and three major lenders were sued in a ...
(RTTNews) - Johnson & Johnson (JNJ) released new 52-week Phase 3 results from the ICONIC-TOTAL study evaluating icotrokinra, a first-in-class oral peptide that selectively blocks the IL-23 receptor in ...
GSK and Spero Therapeutics have shared phase 3 results on their antibiotic candidate, revealing that the oral therapy closely matched the intravenous incumbent in a trial that could support filings ...
Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback